Form D · Biotechnology
BIOLIFE SOLUTIONS INC
Bothell, WA · CIK 0000834365
Offering snapshot reported Oct 27, 2023 · SEC filing
- Reported sold
- $10.4M Offering amount: $10.4M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 19, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 27, 2023 | Initial | $10,374,976 | No comparison | 1 | SEC filing |
| May 18, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-495846
Source: Form D, filed Oct 27, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sarah Aebersold | Executive |
| Todd Berard | Executive |
| Roderick De Greef | Director, Executive |
| Amy Du Ross | Director |
| Rachel Ellingson | Director |
| Karen Foster | Executive |
| Joydeep Goswami | Director |
| Aby Mathew | Executive |
| Tim Moore | Director |
| Geraint Phillips | Executive |
| Michael Rice | Director, Executive |
| Joseph Schick | Director |
| Troy Wichterman | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3303 Monte Villa Parkway
Bothell, WA, 98021
Bothell, WA, 98021